AU7205894A - Purified natural and synthetic compounds for the treatment of osteoarthritis - Google Patents
Purified natural and synthetic compounds for the treatment of osteoarthritisInfo
- Publication number
- AU7205894A AU7205894A AU72058/94A AU7205894A AU7205894A AU 7205894 A AU7205894 A AU 7205894A AU 72058/94 A AU72058/94 A AU 72058/94A AU 7205894 A AU7205894 A AU 7205894A AU 7205894 A AU7205894 A AU 7205894A
- Authority
- AU
- Australia
- Prior art keywords
- osteoarthritis
- treatment
- synthetic compounds
- purified natural
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 201000008482 osteoarthritis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7318993A | 1993-06-08 | 1993-06-08 | |
| US073189 | 1993-06-08 | ||
| PCT/US1994/006490 WO1994028889A1 (en) | 1993-06-08 | 1994-06-08 | Purified natural and synthetic compounds for the treatment of osteoarthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7205894A true AU7205894A (en) | 1995-01-03 |
Family
ID=22112274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU72058/94A Abandoned AU7205894A (en) | 1993-06-08 | 1994-06-08 | Purified natural and synthetic compounds for the treatment of osteoarthritis |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7205894A (en) |
| WO (1) | WO1994028889A1 (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU704429B2 (en) * | 1994-12-01 | 1999-04-22 | Seikagaku Corporation | Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same |
| CA2232527C (en) * | 1995-09-19 | 2008-09-02 | Seikagaku Corporation | Anti-inflammatory agent |
| US5942534A (en) * | 1996-10-10 | 1999-08-24 | The General Hospital Corporation | Photodynamic therapy for the treatment of osteoarthritis |
| WO1998025631A1 (en) * | 1996-12-13 | 1998-06-18 | Lescarden, Inc. | Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine |
| KR100571010B1 (en) | 1997-07-14 | 2006-04-13 | 무라마쯔 다카시 | Drugs containing midkine or its inhibitor as an active ingredient |
| WO2001051054A2 (en) * | 2000-01-12 | 2001-07-19 | University Of North Carolina - Chapel Hill | Use of cyclopentenone derivatives for bone and periodontal regeneration |
| AU2002221935A1 (en) | 2000-12-16 | 2002-06-24 | Aventis Pharma Deutschland Gmbh | Use of low molecular heparin for treating osteoarthritis |
| PL369010A1 (en) | 2001-07-24 | 2005-04-18 | Yale University | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| WO2003024463A1 (en) | 2001-09-15 | 2003-03-27 | Rush-Presbyterian-St. Luke's Medical Center | Stratified cartilage tissue and methods to engineer same |
| US6933298B2 (en) | 2001-12-08 | 2005-08-23 | Aventis Pharma Deutschland Gmbh | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases |
| US20030138873A1 (en) * | 2002-01-22 | 2003-07-24 | Koichi Masuda | Tissue engineered cartilage for drug discovery |
| EP1476471A4 (en) * | 2002-01-23 | 2005-03-16 | Inst Of Nutraceutical Res Pty | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| US6716853B2 (en) | 2002-03-02 | 2004-04-06 | Aventis Pharma Deutschland Gmbh | Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase |
| US7166609B2 (en) | 2002-11-02 | 2007-01-23 | Sanofi-Aventis Deutschland Gmbh | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases |
| US7205315B2 (en) | 2003-09-27 | 2007-04-17 | Sanofi-Aventis Deutschland Gmbh | Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
| FR2864090B1 (en) * | 2003-12-19 | 2006-01-27 | Aventis Pharma Sa | CARBOXY-REDUCED HYALURONIC ACID DERIVATIVES, THEIR PREPARATION, THEIR USE AS A MEDICINAL PRODUCT AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
| FR2864089B1 (en) * | 2003-12-19 | 2006-02-03 | Aventis Pharma Sa | CHONDROID SULFATE CARBOXY-REDUCED DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICINE AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
| FR2864087B1 (en) * | 2003-12-19 | 2006-01-27 | Aventis Pharma Sa | DERMATAN SULFATE CARBOXY-REDUCED DERIVATIVES, THEIR PREPARATION, THEIR MEDICINAL APPLICATION AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
| DE102004004974A1 (en) | 2004-01-31 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Thieno-imino acid derivatives as inhibitors of matrix metalloproteinases |
| US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| JP5368102B2 (en) | 2005-11-17 | 2013-12-18 | バイオミメティック セラピューティクス, インコーポレイテッド | Maxillofacial bone enhancement using rhPDGF-BB and biocompatible matrix |
| AU2007212273B2 (en) | 2006-02-09 | 2013-10-10 | Stryker Corporation | Compositions and methods for treating bone |
| EP2049145B1 (en) | 2006-06-30 | 2018-03-14 | BioMimetic Therapeutics, LLC | Pdgf-biomatrix compositions and methods for treating rotator cuff injuries |
| US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
| CA2735885C (en) | 2008-09-09 | 2018-08-28 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
| CN102811622A (en) | 2010-02-22 | 2012-12-05 | 生物模拟治疗公司 | Platelet-derived growth factor compositions and methods for treating tendinopathy |
| US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
| US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
| US10227369B2 (en) | 2013-03-12 | 2019-03-12 | The Johns Hopkins University | Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications |
| US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2584728B1 (en) * | 1985-07-12 | 1987-11-20 | Choay Sa | PROCESS FOR THE SULFATION OF GLYCOSAMINOGLYCANS AND THEIR FRAGMENTS |
| FR2585576B1 (en) * | 1985-07-30 | 1992-01-03 | Bioetica Sa | BONE MATRIX REPLACEMENT PROMOTING OSTEOGENESIS |
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| US5036056A (en) * | 1987-07-08 | 1991-07-30 | Martin Kludas | Methods for treating damaged corneal, uterine, or cartilage tissue |
| US5171674A (en) * | 1988-07-13 | 1992-12-15 | Brigham And Women's Hospital | Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| US5188959A (en) * | 1989-09-28 | 1993-02-23 | Trustees Of Tufts College | Extracellular matrix protein adherent t cells |
| US5246013A (en) * | 1989-12-22 | 1993-09-21 | Massachusetts Institute Of Technology | Probe, system and method for detecting cartilage degeneration |
| US5158940A (en) * | 1990-02-14 | 1992-10-27 | The United States Government As Represented By The Secretary, Dhhs | Use of suramin to treat rheumatologic diseases |
| US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
-
1994
- 1994-06-08 AU AU72058/94A patent/AU7205894A/en not_active Abandoned
- 1994-06-08 WO PCT/US1994/006490 patent/WO1994028889A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994028889A1 (en) | 1994-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7205894A (en) | Purified natural and synthetic compounds for the treatment of osteoarthritis | |
| AU7419096A (en) | Treatment of vegetables | |
| AU6797094A (en) | Cosmetic treatment of substrates | |
| AU2103295A (en) | Methods for the treatment of thrombosis | |
| AU1173195A (en) | Treatment of immunoregulatory disorders | |
| AU618231B3 (en) | Treatment of emulsions | |
| AU1115095A (en) | Treatment of cellulose | |
| AU3007492A (en) | Treatment of wastewater | |
| AU6253094A (en) | Methods for the treatment of osteoporosis | |
| ZA94338B (en) | Treatment of waste petroleum | |
| AU6723294A (en) | Use of simmondsine | |
| AU1650792A (en) | Treatment of polyurethane surfaces | |
| AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
| AU3553489A (en) | Novel compounds and treatment | |
| AU3380793A (en) | Treatment of waste or other material | |
| AU6662794A (en) | Composition for the treatment of impaired hair growth | |
| AU1604692A (en) | Treatment of longitudinally extending members | |
| AU2875092A (en) | Methods for the treatment of hyperlipidemia using azaspiranes | |
| AU1587295A (en) | The treatment of gaseous substances | |
| AU5813694A (en) | Treatment of plant material | |
| AU8819691A (en) | Treatment of gas | |
| AU3034392A (en) | Treatment of liquids | |
| HK1006290B (en) | Waste treatment | |
| ZA948930B (en) | Treatment of compost | |
| AU5463694A (en) | Process for increasing the protein content of plants |